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Abstract
Background: Genome sequencing of many eukaryotic pathogens and the volume
of data available on public resources have created a clear requirement for a
consistent vocabulary to describe the range of developmental forms of parasites.
Consistent labeling of experimental data and external data, in databases and the
literature, is essential for integration, cross database comparison, and knowledge
discovery. The primary objective of this work was to develop a dynamic and
controlled vocabulary that can be used for various parasites. The paper describes
the Ontology for Parasite Lifecycle (OPL) and discusses its application in
parasite research.
Results: The OPL is based on the Basic Formal Ontology (BFO) and follows the rules
set by the OBO Foundry consortium. The first version of the OPL models complex
life cycle stage details of a range of parasites, such as Trypanosoma sp., Leishmaniasp.,
Plasmodium sp., and Shicstosoma sp. In addition, the ontology also models necessary
contextual details, such as host information, vector information, and anatomical
locations. OPL is primarily designed to serve as a reference ontology for parasite
life cycle stages that can be used for database annotation purposes and in the
lab for data integration or information retrieval as exemplified in the application
section below.
Conclusion: OPL is freely available at http://purl.obolibrary.org/obo/opl.owl and has
been submitted to the BioPortal site of NCBO and to the OBO Foundry. We believe
that database and phenotype annotations using OPL will help run fundamental
queries on databases to know more about gene functions and to find intervention
targets for various parasites. The OPL is under continuous development and new
parasites and/or terms are being added.

Background
Parasitic diseases cause a burden throughout the world [1], but most importantly in
the tropics and subtropics. The protozoan parasite that causes malaria remains a major
threat to global health. In addition to this, important vector-borne parasites include
the protozoa that cause American trypanosomiasis or Chagas disease, leishmaniasis,
Human African Trypanosomiasis (HAT) or sleeping sickness, and the water-borne helminth that causes Schistosomiasis (also known as Bilharzia) [2]. Currently, treatment
© 2012 Parikh et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
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for many of these parasitic diseases is far from ideal. The availability of genome
sequences has become central to research on the biology of these parasites and has
reinvigorated the aim of identifying novel intervention targets [3-5]. The integration
and mining of available data resources is a key challenge to achieve this goal and
several projects, such as the T. cruzi SPSE [6], EuPathDB [7], and VectorBase [8], are
focused on creating effective integration platforms for parasite and vector datasets.
The complexity of parasites and their lifecycle stages requires the use of expressive
and well-defined representation formats that can be consistently and unambiguously
interpreted. To illustrate the complexity of parasite lifecycle stages we consider the Trypanosoma cruzi parasite, which has three stages, namely amastigote, epimastigote, and
trypomastigote. The amastigote is an intracellular form that is found within nucleated
cells of human/vertebrate hosts of the parasite, the epimastigote is found in the midgut
of an insect vector and the trypomastigote is found in the bloodstream of a vertebrate
host. Further, similar lifecycle stages in different organisms may have different locations
and vectors. For example, the epimastigote stage of T. cruzi occurs in the midgut of
the triatomine kissing bug, but in T. brucei one type of epimastigote occurs in the
salivary gland of the tsetse fly, Glossina morsitans, whereas another is present in
the proventricles.
In addition to the complexity of modeling parasite life cycle stages, the parasitic
protozoa datasets are available from multiple genome specific databases. For example,
RMgmDB [9], PlasmoDB [10], andGeneDB [11], for Plasmodium sp; GeneDB, TriTrypDB [12], Trypsproteome [13], VSGDB [14], and TrypanoCyc [15] for the kinetoplastids, and EupathDB [16], CryptoDB [17], or GeneDB for other parasitic protozoans,
such as Cryptosporidium sp., and Eimeria sp. There are now at least 5 different open
access databases for T. brucei [11-14,18] that exist solely to capture and store experimental results. Furthermore, there are several additional databases that have information on species-specific phenotypes and many datasets produced by individual
laboratories that are freely available. Each of these data sources represents parasite information, and insufficient and/or distinct annotations make it difficult to effectively integrate, query and retrieve relevant data.
Ontologies are being increasingly used to address the issue of data heterogeneity in
biomedical research. Ontologies mitigate terminological heterogeneity, ensure consistent interpretation of terms through use of formal logic languages, and also facilitate
automated discovery of implicit knowledge in large datasets. For example, The Gene
Ontology (GO) [19] has enabled a standardized, cross-database, description of gene
products. However, until recently, there has not been a consistent vocabulary for the
description of lifecycle stages in parasitic organisms. In addition, availability of limited
parasite lifecycle and related terms for the bioinformatics tools make it challenging in
analyzing parasite datasets and pose a barrier for linking these tools together. Thus, the
Infectious Disease Ontology (IDO) project (http://infectiousdiseaseontology.org/page/
Main_Page) has initiated development of a family of ontologies including one for vector
borne diseases that already includes an extension covering malaria [20].
The Ontology for Parasite Lifecycle (OPL) complements the efforts of the IDO project by developing an ontology that models complex details of parasite lifecycle stages
including location within the host at each lifecycle stage (within tissue cells of a vertebrate host or midgut of an insect vector, etc.). OPL also describes host and vector
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information and is comprised of rich computational logics that would help query over
multiple data repositories as shown in the Application section below. The current version of OPL covers the parasites that cause Malaria, Chagas disease, Leishmaniasis,
Human African Trypanosomiasis, and Schistosomiasis. Like other ontologies, OPL is
also under continuous development and it will later cover additional eukaryotic
parasites within the GeneDB and EuPathDB databases, to enable consistent curation
and annotation across all of the parasite genome databases currently maintained
by these projects.
In this paper, we describe the current state of OPL and its applications in parasite research. We provide examples of how this ontology can be used to annotate databases
and literature, and for data integration and querying. The current version of OPL (version 2.0) has 339 classes including imported as well as 233 new OPL terms that were
created (as shown in Table 1). OPL reuses terms from other OBO Foundry candidate
ontologies, such as the Ontology for Biomedical Investigation (OBI) [21], the Sequence
Ontology (SO) [22], the Malaria Ontology (IDOMAL) [20], etc. Since OPL shares the
common upper level ontology BFO and common set of relations from the Relation
Ontology [23], it is interoperable with other OBO foundry ontologies. OPL is submitted
to the BioPortal site of the National Center for Biomedical Ontologies (NCBO) [24] for
public use and the OBO Foundry [25]. Below we provide an overview of the ontology
and describe important concepts and their relationships that form the core part of OPL.

Results
OPL modeling and class details
Modeling of lifecycle stages

The OPL terms are represented in single quotes (‘’) throughout this report. The
UBERON: ‘lifecycle stage’ concept was imported and used as the root of all lifecycle
stages created in OPL. Modeling generic lifecycle of all the parasites was intricate since
it involved various stages and sub-stages. Moreover, there are at least two possible ways
Table 1 Statistics of OPL specific terms and imported terms from different resources
Ontology

Class Number

Ontology for Parasites Lifecycle (OPL)

233

Basic Formal Ontology (BFO)

39

NCB ITaxonomy (NCBITAXON)

22

Uber anatomy ontology (UBERON)

14

Infectious Disease Ontology (IDO)

5

Cell Type Ontology (CL)

3

Malaria Ontology (IDOMAL)

3

Brend a Tissue Ontology (BTO)

2

Common Anatomy Reference Ontology (CARO)

2

Ontology for Biomedical Investigations (OBI)

2

Information Artifact Ontology (IAO)

6

Obo In Owl

6

owl

2

Total

339
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to describe lifecycle stages; (i) generic lifecycle stages, such as sporozoite stage or epimastigote stage, and (ii) organism-specific lifecycle stages, such as P. falciparum
sporozoite stage, T. cruzi epimastigote stage or T. brucei epimastigote stage. The
organism-specific lifecycle stages provides clear information that ‘P. falciparum sporozoite stage’ > has_participant > only ‘P. falciparum sporozoite’ and not any other kind of
parasitic species. This type of modeling will help avoid any wrong assumption at a later
stage since the term ‘sporozoite stage’ can be applied to other parasitic species (even
non-Plasmodium) as well. However, describing generic lifecycle stages is also important
since more than one organism may have a sporozoite stage in their lifecycle. Therefore,
OPL created generic lifecycle stage terms under the class UBERON: ‘lifecycle stage’.
OPL also modeled parasite specific lifecycle stages under the specific class ‘Parasite lifecycle stage’. This subdivision of parasite’s lifecycle was defined as UBERON: ‘lifecycle
stage’ and has_participant only ‘parasite organism’ (Figure 1). Parasite specific lifecycle
stages were created in the same pattern using the has_participant relation. For example,
the (‘T. cruzi epimastigote stage’ was defined as ‘epimastigote stage’ and has_participant
only ‘Trypanosoma cruzi epimastigote’) (Figure 2). Through this logical definition,
we avoid the issue of asserted multiple-inheritance. As shown in Figure 1, ‘T. cruzi epimastigote stage’ is an ‘epimastigote stage’ and a ‘T. cruzi lifecycle stage’ as well. It was
asserted as an ‘epimastigote stage’ and inferred as a ‘T. cruzi lifecycle stage’ after reasoning (Figure 2).
Like other processes, lifecycle stages require location information as well. It is very
important to model the location of the lifecycle stage since different stages may have

Figure 1 OPL Schema.
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Figure 2 Modeling of Parasite specific lifecycle stages in OPL.

different hosts or may occur in different anatomical structures of the same host. For example, the T. cruzi epimastigote stage occurs in the midgut of the Triatominae and the
T. brucei epimastigote stage occurs in the salivary gland of Glossina flies. To capture
such facts, we used the unfolds_in relationship that is used between a ‘processual_entity’
and a ‘continuant’ [23] to describe ‘T. cruzi epimastigote stage’ > unfolds_in > ‘Triatominae
midgut’. For this purpose, terms for organism-specific anatomical structures were also
created as mentioned in the section below.
Modeling of parasite organisms and anatomical structures

Two subclasses of Material Entity, Organism and Anatomical Structure are imported
from OBI and Common Anatomy Reference Ontology (CARO) [26], respectively. Some
subclasses of Organism are imported from the IDOMAL and NCBI taxonomy (http://
purl.bioontology.org/ontology/NCBITaxon). However, new OPL-specific classes have
been created under specific organisms to describe the organism in a particular lifecycle stage, such as ‘T. cruzi epimastigote’, ‘P. falciparum sporozoite’, etc. (Figure 1).
Further, the location of the parasite in a particular lifecycle stage was captured using
the located_in property used between two continuants [23]; i.e., ‘T. cruzi epimastigote’ > located_in > some ‘Triatominae midgut’. A connection of the parasite to
the lifecycle stage, however, was captured using participates_in property. For example,
‘T. cruzi epimastigote’ > participates_in > only ‘T. cruzi epimastigotestage’.
Similarly, new classes for anatomical structures were created for specific organisms,
for example, ‘Anopheles salivary gland’ or ‘Homo sapiens hepatocyte.’ This was done to
avoid any confusion in the similarity of anatomical structures of various organisms.
Many times insect anatomical structures are made out of only one kind of tissue in
contrast to vertebrates, in which there are more than one tissue or cell types present in
a typical organ. Thus, to capture the difference between the mosquito salivary gland
and human salivary gland, anatomical structures were classified into organism-specific
structures. Such concepts were modeled using part_of property. For example, the term
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‘Anopheles salivary gland’ was defined as “UBERON: Salivary Gland and (part_of some
NCBI Taxon: Anopheles).” The class ‘Salivary Gland’ was imported from UBERON [27]
since it defines salivary gland in general and not any species specific anatomical
structure. Further, OPL captures restrictions between parasites and their hosts using
located_in property. For instance, ‘P. falciparumsporozoites’ > located in > some
(‘Anopheles salivary gland’ or ‘human hepatocyte’). Finally, some classes under Anatomical Structure are imported from the Cell type Ontology (CL) [28] and BRENDA Tissue
Ontology (BTO) [29].
Applications/use cases
Database annotations and queries

The Pathogen Genome database (GeneDB) [11] is responsible for the active curation
and annotation of several parasitic organism reference genomes, namely Trypanosoma
brucei, Trypanosoma cruzi, Leishmania major, Plasmodium falciparum, and Schistosoma mansoni, as well as curating and annotating the genomes of numerous related
organisms. The annotated genomes are then used by databases such as EuPathDB to be
integrated with a wide variety of functional genomics datasets made available by members of the global research community, and thus accurate and consistent annotation is
essential. The OPL is being used by the Wellcome Trust Sanger Institute (WTSI) to annotate their GeneDB that will help run structured queries on the database (Figure 3).
One example query is, “list all the genes that encode a surface protein in P. falciparum
sporozoite stage.” Running such queries on the database will help researchers to answer
fundamental questions on gene function. Currently, all annotations that include a lifecycle stage description fall into the category of phenotype curation.
Phenotype annotations are a key aspect of the curation process, in which experimental
results are entered into the database in a standardized format. The new controlled curation system draws terms from several ontologies to create a statement about a phenotype
that is associated with a gene model. Since the majority of experiments carried out in
parasitic organisms are done in a single lifecycle stage, it is important to annotate phenotype data with this information to enable users to analyze the data appropriately. Further,
there is a wide range of terms used to describe lifecycle stages within each parasite species, which makes searching the phenotype curation more complex than it needs to be.
The OPL, however, now provides standardized terms for lifecycle stages across all of the
genomes that are actively curated by GeneDB. OPL will be combined with other available
ontologies, such as GO, to add a depth of information to curations, enabling users to
identify not only the lifecycle stage in which a phenotype was observed, but also the cellular compartment and the biological process with which it is associated. Examples of GeneDB phenotype annotation in T. brucei, which can utilize OPL include:
A.

T. brucei bloodstream form trypomastigote stage
1.

2.

Tb927.10.10390 Trypanothione Reductase.
Current curation = loss-of-function mutant phenotype: lethal during
bloodstream stage.
Tb927.8.2210 Pteridine Reductase.
Current curation = RNAi phenotype: essential in bloodstream form.
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Figure 3 Use of OPL for Annotations of Parasite Lifecycle Stages in GeneDB.

3.

B.

Tb927.7.5930 Protein Associated With Differentiation.
Current curation = expressed in stumpy form.

T. brucei procyclic trypomastigote stage
4

5
6.

Tb927.5.2900 Histone Deacetylase 4.
Current curation = conditional null mutant phenotype: essential for fly
midgutcolonisation.
Tb11.02.2260 MCAK-like kinesin, putative.
Current curation = gene deletion: no effect on growth in procyclic form
Tb927.3.4290 Paraflagellar Rod Protein.
Current curation = RNAi: decreased cell motility during procyclic stage.

In both of these examples, the OPL term will be used to replace the ambiguous and
inconsistent terms currently in use for annotation. As a team of curators carries out
phenotype annotation manually, OPL usage will remove any ambiguity and inconsistency in the descriptions of lifecycle stages associated with phenotypes. EuPathDB will
also use OPL for annotation of investigations in which lifecycle stages represent an important context [30]. To address community needs, EuPathDB collects datasets for a
wide variety of eukaryotic parasite species from both individual investigations and external resources. OPL and other ontologies that follow OBO Foundry principles (such
as GO and OBI) will be used to provide consistent representation of experimental contexts such as the lifecycle stage for which phenotype data was collected. Consistent
usage of terms from OPL and other ontologies will facilitate sharing and exchanging
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data among different resources, integration of data from external resources, such as
genome data from GeneDB, and data exploration and analysis.
Literature annotation

Other than genomics databases, such as EuPathDB or GeneDB, a large volume of experimental biological information is also buried in the fast-growing literature databases,
such as PubMed. Therefore, research institutes like the WTSI have initiated efforts to
annotate scientific literature using ontologies. They currently use Artemis [31], which
provides a platform to annotate the scientific literature using GO. Now they will be able
to annotate parasite lifecycle stages and other details using OPL. To annotate the lifecycle stages and other details in the literature either Artemis can be extended to include OPL, or another tool, such as Kino [32], can be used for this purpose. Kino is a
document management system that researchers at the Ohio Center of Excellence for
Knowledge-enabled Computing (Kno.e.sis) at the Wright State University developed
along with WTSI using SA-REST and faceted search. Kino allows biologists to annotate
any web documents using ontologies listed at the NCBO BioPortal, submit them to a
Kino repository, and search them using ontology terms or synonyms (Figure 4). Currently, WTSI is evaluating their existing system and Kino for the use in annotating
PubMed literature in parasite domains that will utilize OPL.
Data integration and knowledge discovery

OPL is currently being used in the Semantic Problem Solving Environment (SPSE) for
T. cruzi project along with the Parasite Experiment Ontology (PEO) [33,34]. T. cruzi
SPSE is a collaborative effort among researchers at the Kno.e.sis Center at the Wright
State University, the Center for Tropical and Emerging Global Diseases (CTEGD) at the
University of Georgia, and the National Center for Biomedical Ontologies (NCBO) at
the Stanford University. The primary objective of this research is to develop a comprehensive and intuitive environment using semantic web technologies that will facilitate
the identification of vaccine, diagnostic, and/or gene knockout targets in T. cruzi and
related parasites. For this purpose, OPL, along with PEO, were used as reference ontologies to convert the data into a Resource Description Framework (RDF) format and semantically integrate data from various information sources, such as pathway, ortholog,
and gene information resource. PEO was also used to develop forms to capture the
provenance data in the biology lab. These forms use a user-friendly interface and generate the output data in RDF format based on ontology schema. OPL can be used effectively for this purpose and also to provide consistent labeling of parasite research data
that involves lifecycle stages. The forms that use ontologies as schema facilitate consistent labeling of the data and make data integration easier at later stages. The client can
either use SPARQL queries or a query processing tools like Cuebee [35] to query such
semantically integrated datasets and find new knowledge such as intervention targets
for parasites. Some example queries that utilize OPL for this purpose are:
1) Compare the gene expression profile of different parasites that are found in
human macrophages.
2) Compare all the P. falciparum genes that are expressed during vector-based
lifecycle stages and not during vertebrate-host lifecycle stages.
3) Show all the enzymes expressed during the slender trypomastigote stage in the
glycosome and not expressed in the procyclic stage.
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Figure 4 Literature Annotation of Lifecycle Terms using OPL.

4) List all the T. cruzi genes that are expressed in amastigote stage only. Also, how
many of these genes are involved in only one metabolic pathway.
Some databases including EuPathDB do not collect information regarding parasite
vectors and anatomical locations in a structured manner. OPL will be very important
for such databases and it will enable users to query the databases for such information
(please see Query 1 and 2), by providing an additional, potential interoperability tool
between, for example, EuPathDB and VectorBase. OPL can also be used along with
other ontologies, such as GO or PEO to find vaccination, drug, or gene knockout targets in parasites (Query 3 and 4) [34].

Discussion and conclusion
OPL is a collaborative effort among national and international institutes with expertise
in parasite and vector research, ontology development, semantic web, and bioinformatics. OPL describes complex lifecycle stage details of various parasites along with their
host, vector, and anatomical location information. Since the sequences of many parasite
genomes are available publicly on GeneDB, GenBank, and EuPathDB, annotation of
gene products has become a priority. Moreover, consistent labeling of parasite data including external databases, experimental data, and literature, is essential in data integration, cross database comparison, and uniform data access. Currently the only aspect
of annotation that is structured uses the Gene Ontology (GO) in conjunction with an
evidence code that describes the experiment type used to generate the data. This gives
users the ability to search the database according to GO annotations. Since not every
phenotype can be described using GO terms alone, GeneDB is building a controlled
phenotype curation system that will utilize GO in combination with other relevant
ontologies. For such a curation system, the annotation of parasite lifecycle stages for
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the experimental data is very desirable to GeneDB and EuPathDB users. Since a lifecycle ontology for parasitic organisms was not already available, the creation of OPL is
expected to have a significant impact on the curation process of parasite data. Using
OPL and other ontologies, the vast wealth of parasite knowledge can be used effectively
by parasite experts, database developers, and technicians developing decision support
tools to control such diseases. Moreover, such ontologies can be used to structure the
parasite phenotype data and to allow queries on these databases. The data integration
and annotations using OPL also helps parasite researchers to (i) advance their understanding of gene function, (ii) interpret functional genomics datasets, (iii) query phenotypes to find intervention targets, and (iv) facilitate integration of various data sources
as exemplified in the Application section above.
OPL complies with the OBO Foundry principles and reuses many terms from existing OBO Foundry ontologies, such as OBI, CL, CARO, UBERON, and BTO. As more
data annotated using OPL become available, its utility to the broader parasite research
community will continue to increase. The latest version of OPL (current is v 2.0) is always available at http://purl.obolibrary.org/obo/opl.owl and also posted on BioPortal
site of NCBO (http://purl.bioontology.org/ontology/OPL) for public use.
In summary, OPL represents a significant effort to model the complex lifecycle of
various parasites including information on their host, vector, and anatomical location.
As shown in the application and use cases, we believe that consistent labeling of parasite data and database annotations using OPL will facilitate data integration and uniform data access, and also help parasitologists answer the fundamental question of
what a gene product does in a specific lifecycle stage.

Method
OPL is developed using the Basic Formal Ontology (BFO) [36] as upper level ontology
and follows the principles set by the OBO Foundry consortium [37]. OPL is expressed
in the W3C standard Web Ontology Language (OWL) 1.0 as it supports richer semantics than the Open Biomedical Ontologies (OBO) format, another commonly used language in the biomedical domain. The OWL Description Logic (OWL-DL) was chosen
to gain maximum expression and support for the automated reasoning, inferences, and
consistency-checking are important for ontology development and maintenance. The
meta-data schema of OPL is implemented as OWL annotation properties defined in
the Information Artifact Ontology (IAO, http://purl.obolibrary.org/obo/iao), which have
been widely used by many OBO foundry ontologies, such as IDO [38] and OBI. Two
key external ontologies, BFO and IAO meta-data part, are directly imported into OPL
using the owl:import mechanism which imports the whole ontologies.
To eliminate the redundant efforts and ensure orthogonality, OPL maximizes the use
of existing ontologies already listed by the OBO foundry. Since importing the whole
ontology is impractical, Minimal Information Reference External Ontology Term (MIREOT) strategy [39] is adopted to import the terms from the external resources. This
strategy provides the consistency, flexibility, and scalability of referring the external
resources. The minimal information of an external term includes source ontology URI,
source term URI, and target direct superclass URI. The OPL mainly references terms
in four reference ontologies, IDO for existing parasite related terms, NCBI taxon
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(http://purl.bioontology.org/ontology/NCBITaxon) for organism, Cell Ontology for cell
type, and UBERON Ontology for cross species anatomical structure. OPL provides the
textual definitions for all the terms and logical definitions for each term when possible.
The ontology was initially developed using Protégé 4.1 (http://protege.stanford.edu/),
later switching to the WebProtege ontology editor [40] since it provides a better collaborative working environment and allows the developers to track changes made by
others. The reasoner tools, such as Hermit (http://hermit-reasoner.com/) or Pellet [41],
were used for consistency checking and inferences.
The terms in OPL were collected from our collaborators and the community members who intend to use OPL. The ontology will continue to expand to meet the needs
of a parasite research community to cover more eukaryotic parasites and their lifecycle
stages. The BioPortal or Trykipedia site (http://wiki.knoesis.org/index.php/Trykipedia)
will be used to collect more terms in the future. The current developmental version of
OPL is available at: http://webprotege.stanford.edu/#OPL. We plan to release new inferred versions of OPL quarterly, if required, to provide any new updates on the ontology. During the release process, the permanent OPL identifiers will be assigned and the
compliance with OBO policies will be checked. The releases of OPL will also be
uploaded to both the NCBO BioPortal and the OBO Foundry repository for public use.

Availability of supporting data
The web Protégé link for OPL development, http://webprotege.stanford.edu/, shows
the change history and developers’ comments, discussion, and the reason for
changes made.
The queries and results of the Semantic Problem Solving Environment (SPSE) for
T. cruzi project where OPL was used along with other ontologies can be found here:
http://wiki.knoesis.org/index.php/Manuscript_Details.
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